ENT Diagnostics and Therapeutics

Head and Neck Oncology: Early Detection and Targeted Therapy

This track focuses on the prevention, diagnosis, and treatment of benign and malignant tumors affecting the head and neck region, including the larynx, pharynx, thyroid, salivary glands, and oral cavity. The session will explore innovations in molecular diagnostics, imaging, robotic-assisted surgeries, and targeted immunotherapies.Participants will learn about personalized treatment strategies, precision radiotherapy, and surgical reconstruction techniques that are transforming cancer care. Emphasis will also be placed on survivorship, rehabilitation, and quality of life after treatment. This session is ideal for oncologists, head and neck surgeons, and radiologists. The track will further examine biomarkers for early detection, HPV-related head and neck cancers, and the integration of genomic profiling to guide therapeutic decisions. Attendees will gain insights into minimally invasive surgical approaches, organ preservation protocols, and the management of treatment-related side effects such as dysphagia, xerostomia, and voice loss. Case studies and panel discussions will explore multidisciplinary team approaches, highlighting collaboration between oncology, ENT, pathology, and speech therapy. The importance of psychosocial support, nutritional counseling, and long-term follow-up care will also be addressed. This session aims to provide a comprehensive framework for delivering cutting-edge, compassionate, and individualized oncology care.